- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Integral Diagnostics Ltd (IDX)
Assess today's live Integral Diagnostics Ltd (IDX) share price, performance and insights using our live Sydney: IDX stock exchange data.
Analyse the historical data and Integral Diagnostics Ltd share price performance charts on this page. Our technical summary section provides analysis on Integral Diagnostics Ltd share price buy/sell indicators using real-time data (or discuss the Integral Diagnostics Ltd (IDX) stock price today with other investors in the Integral Diagnostics Ltd ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX IDX share price (ISIN: AU000000IDX2) to enhance your trading decisions with our free investment tools and resources.
What Is the Integral Diagnostics Ltd Share Price Today?
The Integral Diagnostics Ltd share price today is 2.26.
What Is the Stock Symbol for Integral Diagnostics Ltd
The stock symbol (or 'ticker') for Integral Diagnostics Ltd is "IDX."
What Stock Exchange Does Integral Diagnostics Ltd Trade On?
Integral Diagnostics Ltd is listed and trades on the Sydney stock exchange.
Is Integral Diagnostics Ltd a Good Stock to Buy?
Determining whether Integral Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Integral Diagnostics Ltd share price performance charts on this page. Our technical summary section provides analysis on Integral Diagnostics Ltd share price buy/sell indicators using real-time data (or discuss the Integral Diagnostics Ltd (IDX) stock price today with other investors in the Integral Diagnostics Ltd ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX IDX share price (ISIN: AU000000IDX2) to enhance your trading decisions with our free investment tools and resources.
What Is the Integral Diagnostics Ltd Share Price Today?
The Integral Diagnostics Ltd share price today is 2.26.
What Is the Stock Symbol for Integral Diagnostics Ltd
The stock symbol (or 'ticker') for Integral Diagnostics Ltd is "IDX."
What Stock Exchange Does Integral Diagnostics Ltd Trade On?
Integral Diagnostics Ltd is listed and trades on the Sydney stock exchange.
Is Integral Diagnostics Ltd a Good Stock to Buy?
Determining whether Integral Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Sydney
Currency in AUD
2.26
-0.14(-5.83%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.26
2.53
52 wk Range
1.91
3.07
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.262.53
52 wk Range
1.913.07
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.24
Upside
+43.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Integral Diagnostics Ltd Company Profile
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.
Integral Diagnostics Ltd Earnings Call Summary for H1/2026
- Revenue jumped 55.6% to 393.5M AUD in H1 FY2026, driven by Capital Diagnostics merger and organic growth in Australia and New Zealand.
- Operating EBITDA surged 75.6% to 81.1M AUD with margins expanding 230 bps to 20.6%; operating NPAT increased 154.6% to 22.3M AUD.
- Interim dividend raised 32% to 0.033 AUD per share; net debt-to-EBITDA improved to 2.5x from 2.8x, strengthening balance sheet.
- Company expects continued growth from MRI deregulation, teleradiology expansion (radiologist base up 33%), and government health initiatives.
- Stock declined 2.08% to 2.4 AUD despite strong results; key risks include integration costs, labor shortages, and competitive pressures.
Last Updated: 24/02/2026, 01:40
Read Full TranscriptCompare IDX to Peers and Sector
Metrics to compare | IDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 191.4x | 18.0x | −0.6x | |
PEG Ratio | 1.81 | −0.86 | 0.00 | |
Price/Book | 1.3x | 1.2x | 2.6x | |
Price / LTM Sales | 1.4x | 0.6x | 3.3x | |
Upside (Analyst Target) | 37.5% | 21.4% | 45.0% | |
Fair Value Upside | Unlock | 27.8% | 6.1% | Unlock |
Analyst Ratings
12 Buy
0 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.24
(+43.36% Upside)
Earnings
Latest Release
Aug 25, 2025
EPS / Forecast
0.01 / 0.0609
Revenue / Forecast
374.34M / 247.07M
People Also Watch
FAQ
What Is the Integral Diagnostics Ltd (IDX) Share Price Today?
The live Integral Diagnostics Ltd share price today is 2.26
What Stock Exchange Does Integral Diagnostics Ltd (IDX) Trade On?
Integral Diagnostics Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Integral Diagnostics Ltd?
The stock symbol (also called a 'ticker') for Integral Diagnostics Ltd is "IDX."
Does Integral Diagnostics Ltd Pay Dividends? What’s The Current IDX Dividend Yield?
Yes, IDX Pays Dividends to its Shareholders. The current Integral Diagnostics Ltd dividend yield is 2.88%.
What Is the Current Integral Diagnostics Ltd Market Cap?
As of today, Integral Diagnostics Ltd market capitalisation is 868.42M.
What Is Integral Diagnostics Ltd's (IDX) Earnings Per Share (TTM)?
The Integral Diagnostics Ltd EPS is currently 0.02 (Trailing Twelve Months).
Is IDX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Integral Diagnostics Ltd moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Integral Diagnostics Ltd Stock Split?
Integral Diagnostics Ltd has split 1 times. (See the IDX stock split history page for full effective split date and price information.)
How Many Employees Does Integral Diagnostics Ltd Have?
Integral Diagnostics Ltd has 3025 employees.
What is the current trading status of Integral Diagnostics Ltd (IDX)?
As of 24/02/2026, Integral Diagnostics Ltd (IDX) is trading at a price of 2.26, with a previous close of 2.40. The stock has fluctuated within a day range of 2.26 to 2.53, while its 52-week range spans from 1.91 to 3.07.
What Is Integral Diagnostics Ltd (IDX) Price Target According to Analysts?
The average 12-month price target for Integral Diagnostics Ltd is AUD3.24, with a high estimate of AUD4 and a low estimate of AUD2.1. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +43.36% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.